BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35487435)

  • 1. Improving organs-at-risk sparing for choroidal melanoma patients: A CT-based two-beam strategy in ocular proton therapy with a dedicated eyeline.
    Fleury E; Trnková P; van Rij C; Rodrigues M; Klaver Y; Spruijt K; Naus N; Zolnay A; Pignol JP; Kiliç E; Hoogeman MS
    Radiother Oncol; 2022 Jun; 171():173-181. PubMed ID: 35487435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical note: Impact of beam properties for uveal melanoma proton therapy-An in silico planning study.
    Wulff J; Koska B; Janson M; Bäumer C; Denker A; Geismar D; Gollrad J; Timmermann B; Heufelder J
    Med Phys; 2022 May; 49(5):3481-3488. PubMed ID: 35218037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique.
    Hartsell WF; Kapur R; Hartsell SO; Sweeney P; Lopes C; Duggal A; Cohen J; Chang J; Polasani RS; Dunn M; Pankuch M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):353-359. PubMed ID: 27084652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
    Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison.
    Fleury E; Trnková P; Spruijt K; Herault J; Lebbink F; Heufelder J; Hrbacek J; Horwacik T; Kajdrowicz T; Denker A; Gerard A; Hofverberg P; Mamalui M; Slopsema R; Pignol JP; Hoogeman M
    Med Phys; 2021 Aug; 48(8):4506-4522. PubMed ID: 34091930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
    Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
    Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
    Rana S; Zheng Y
    J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.
    Gerard A; Peyrichon ML; Vidal M; Barnel C; Sauerwein W; Carnicer A; Angellier G; Mathis TM; Mishra KK; Thariat J; Herault J
    Cancer Radiother; 2022 Nov; 26(8):1027-1033. PubMed ID: 35803862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy.
    Fleury E; Trnková P; Erdal E; Hassan M; Stoel B; Jaarma-Coes M; Luyten G; Herault J; Webb A; Beenakker JW; Pignol JP; Hoogeman M
    Med Phys; 2021 Mar; 48(3):1315-1326. PubMed ID: 33336379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
    Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
    Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
    Patel AV; Lane AM; Morrison MA; Trofimov AV; Shih HA; Gragoudas ES; Kim IK
    Ophthalmology; 2016 Feb; 123(2):369-377. PubMed ID: 26545316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and commissioning of the non-dedicated scanning proton beamline for ocular treatment at the synchrotron-based CNAO facility.
    Ciocca M; Magro G; Mastella E; Mairani A; Mirandola A; Molinelli S; Russo S; Vai A; Fiore MR; Mosci C; Valvo F; Via R; Baroni G; Orecchia R
    Med Phys; 2019 Apr; 46(4):1852-1862. PubMed ID: 30659616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration group.
    Stock M; Gora J; Perpar A; Georg P; Lehde A; Kragl G; Hug E; Vondracek V; Kubes J; Poulova Z; Algranati C; Cianchetti M; Schwarz M; Amichetti M; Kajdrowicz T; Kopeć R; Mierzwińska G; Olko P; Skowrońska K; Sowa U; Góra E; Kisielewicz K; Sas-Korczyńska B; Skóra T; Bäck A; Gustafsson M; Sooaru M; Witt Nyström P; Nyman J; Björk Eriksson T
    Acta Oncol; 2019 Dec; 58(12):1720-1730. PubMed ID: 31393203
    [No Abstract]   [Full Text] [Related]  

  • 16. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.